7-Oct-2026
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
PRNewswire (Thu, 8-Oct 7:03 AM ET)
Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
PRNewswire (Wed, 7-Oct 7:06 AM ET)
Globe Newswire (Tue, 6-Oct 9:15 AM ET)
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
PRNewswire (Tue, 6-Oct 7:04 AM ET)
Servier Adopts Veeva OpenData Globally to Scale AI
PRNewswire (Wed, 30-Sep 7:03 AM ET)
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
PRNewswire (Thu, 24-Sep 7:03 AM ET)
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
PRNewswire (Wed, 23-Sep 7:04 AM ET)
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels
PRNewswire (Mon, 21-Sep 7:03 AM ET)
Leading Biotech Selects Veeva Vault CRM Globally
PRNewswire (Tue, 15-Sep 7:04 AM ET)
The Market Just Told You Which Layer Of AI Biology It Is Paying For
Globe Newswire (Thu, 3-Sep 2:10 PM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of October 7, 2026, VEEV stock price declined to $282.50 with 935,108 million shares trading.
VEEV has a beta of 1.06, meaning it tends to be more sensitive to market movements. VEEV has a correlation of 0.07 to the broad based SPY ETF.
VEEV has a market cap of $45.74 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $928 million in Revenue and $2.35 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.25.
In the last 3 years, VEEV traded as high as $310.50 and as low as $148.05.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VOO, VO, IVV, VUG.
VEEV has underperformed the market in the last year with a return of -7.7%, while SPY returned +17.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VEEV shares. However, VEEV has outperformed the market in the last 3 month and 2 week periods, returning +46.9% and +4.3%, while SPY returned +4.2% and +1.2%, respectively. This indicates VEEV has been having a stronger performance recently.
VEEV support price is $277.60 and resistance is $289.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV shares will trade within this expected range on the day.
